Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 4Expanded_access 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 1Breast Neoplasms 1

Interventions

abemaciclib 2Alpelisib 2zenocutuzumab 1tucatinib 1selpercatinib 1ribociclib 1pegilodecakin 1iniparib 1eribulin 1Proton Pump Inhibitors 1Lapatinib 1Hydrocortisone 1Everolimus 1Capecitabine 1Ado-Trastuzumab Emtansine 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Breast Neoplasms × iniparib × Clear all
NCT01130259 2013-09-17

An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer

Sanofi

No longer available
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡